Biotech Values

[rkrw]

That's not exactly what I said. What I meant was IF Teva is approved I don't think it's unreasonable to expect around $300M in sales or $30M/year in royalties as the market gets sliced a few ways. This is just an estimate. We don't know if Teva will be approved soon, within two years, or not.